Home/Filings/4/0000899243-22-002870
4//SEC Filing

Brudnick Richard 4

Accession 0000899243-22-002870

CIK 0001659352other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:06 PM ET

Size

8.1 KB

Accession

0000899243-22-002870

Insider Transaction Report

Form 4
Period: 2022-01-19
Brudnick Richard
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-19+41,00041,000 total
    Exercise: $7.21Exp: 2032-01-18Common Stock (41,000 underlying)
  • Award

    Restricted Stock Units

    2022-01-19+8,4008,400 total
    Common Stock (8,400 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on January 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]On January 19, 2022, the reporting person was granted 8,400 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Issuer

Codiak BioSciences, Inc.

CIK 0001659352

Entity typeother

Related Parties

1
  • filerCIK 0001692359

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:06 PM ET
Size
8.1 KB